Definition of a Biocidal Product
A biocidal product refers to:
- Any substance or mixture, in the form in which it is supplied to the user, consisting of, containing or generating one or more active substances, with the intention of destroying, deterring, rendering harmless, preventing the action of, or otherwise exerting a controlling effect on, any harmful organism by any means other than mere physical or mechanical action.
- Any substance or mixture, generated from substances or mixtures which do not themselves fall under the first indent, to be used with the intention of destroying, deterring, rendering harmless, preventing the action of, or otherwise exerting a controlling effect on, any harmful organism by any means other than mere physical or mechanical action.
- A treated article that has a primary biocidal function shall be considered a biocidal product.
BPR Helpdesk in Estonia
Health Board (Terviseamet)
Department of Chemicals Safety
Paldiski mnt 81, 10614 Tallinn
Email: [email protected]
Additional Information
Information on BPR in ECHA
Consolidated text of BPR
Placing Biocidal Products on the Market
Biocidal products shall not be made available on the market or used unless:
- authorised in accordance with the EU Biocides Regulation, or
- registered during the transitional period in accordance with Estonian Biocides Act.
Before placing a biocidal product on the Estonian market for a particular type of product you will need to ensure that the active substance is either approved or under review in that product type. The status of the active substance can be checked on the ECHA webpage.
If the active substance is still under the BPR review program, national requirements on transitional period apply to the biocidal product. In this case, the biocide needs to be registered or the change requested.
To register your biocide or to request changes to an already registered biocide, please e-mail the BPR Helpdesk at [email protected] with the following documents:
- Completed and signed application form
- Authorization of representation (if the applicant is not the producer of the biocidal product). A document certifying the right of representation, in which the producer of the biocidal product gives permission to the applicant for registering the biocidal product.
- Proof of active substance use. A document proving the use of the active substance(s) from the manufacturer/supplier who is included in the BPR Art 95 list, such as a purchase document, completed and signed self-declaration, or letter of confirmation.
- Safety Data Sheet for each active substance.
- Performed efficacy test(s) report(s) for products in Product Type 1.
- Receipt of fee payment.
Fees
- The fee for the registration is 400 EUR per biocidal product or per family.
- The fee for the change of the registration is 150 EUR per registration certificate.
- The fee for the administrative change of the registration certificate is 50 EUR per registration certificate.
All bank transfer charges to appliers account.
Bank Details
- Beneficiary customer: RAHANDUSMINISTEERIUM (Ministry of Finance)
- Beneficiary's accounts:
SEB Bank EE891010220034796011 (BIC/SWIFT: EEUHEE2X)
Swedbank EE932200221023778606 (BIC/SWIFT: HABAEE2X)
LHV Bank EE777700771003813400 (BIC/SWIFT: LHVBEE22)
Luminor Bank EE701700017001577198 (BIC/SWIFT: RIKOEE22)
- Payment details: Terviseamet - 2900082304, name of biocide.
The Health Board will respond to your application within 30 calendar days.
The registration certificate issued during the transitional period remains valid until either the approval of the active substance(s) or December 31, 2030 (in accordance with BPR Art. 89(1)).
Please note that Article 45 of the CLP Regulation applies for biocidal products. In case you have additional questions related to Article 45 notification, please contact the CLP Helpdesk at [email protected].
For the biocidal product added to the list of the registered biocidal products:
- The producer is responsible for controlling and ensuring the efficacy of the product and for labelling the product according to the requirements.
- Listing the product shows that the required information have been submitted to the Health Board and that the product can be made available and used in Estonia.
Active substances need to be approved before an authorisation for a biocidal product containing them can be granted.
Further information: ECHA's webpage.
Companies wishing to submit an application to the Health Board for the approval of an active substance, are kindly asked to fill in the downloadable request form below and send it to BPR Helpdesk in Estonia at [email protected].
Fees and charges
Please note that in Estonia for biocide application procedures the amount of fee consists of 2 parts: a state fee (non-refundable) + an evaluation fee (refundable, as based on actual expenses). Depending on actual costs of evaluation Health Board refunds excess amounts paid or asks the applicant to pay extra, but never more than maximum evaluation fee.
- State fees are provided in the State Fees Act
- Charges for the evaluation are provided in the Biocidal Products Act
Type of application |
State Fee, €(non-refundable) |
Evaluation charge, €(refundable as based on actual expenses) |
| An approval of an active substance (including inclusion in BPR Annex I) - Estonia acts as the evaluating Competent Authority - eCA | 3300 | min 71 600 – max 624 200 |
Last updated: 13.03.2026
